This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Neilson AR, Deeg M, Runge C, Sieper J.Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. 10th Annual Congress of the European League Against Rheumatism: abstr. SAT0250, 10 Jun 2009. Available from: URL: http://www.eular.org
Taylor SD, Jansen JP, Pellissier JM, Chambers J.Cost-effectiveness evaluation of etoricoxib vesus celecoxib and non-selective NSAIDs in the treatment of ankylosing sponylitis in Norway. 10th Annual Congress of the European League Against Rheumatism: abstr. AB0718, 10 Jun 2009. Available from: URL: http://www.eular.org
Edwards NL, Baraf HS, Becker MA, Gutierrez-Urena SR, Sundy JS, Treadwell EL, Vazquez-Mellado J, Yood RA, Strand V, Kawata AK, Horowitz Z, Huang B, Maroli A, Waltrip R.Health-related quality of life (HRQOL) and disability index: results from GOUT1 and GOUT2. 10th Annual Congress of the European League Against Rheumatism: abstr. FRI0544, 10 Jun 2009. Available from: URL: http://www.eular.org
Tosh JC, Wailoo AJ.Combination DMARDs for rheumatoid arthritis: a cost-effectiveness analysis. 10th Annual Congress of the European League Against Rheumatism: abstr. SAT0141, 10 Jun 2009. Available from: URL: http://www.eular.org
Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G.The cost effectiveness of pregabalin in the treatment of fibromyalgia. 10th Annual Congress of the European League Against Rheumatism: abstr. SAT0452, 10 Jun 2009. Available from: URL: http://www.eular.org
Rights and permissions
About this article
Cite this article
News from EULAR. Pharmacoecon. Outcomes News 583, 7 (2009). https://doi.org/10.2165/00151234-200905830-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905830-00014